HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raúl Adrover Selected Research

Aftercare (After-Treatment)

1/2019Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raúl Adrover Research Topics

Disease

2Chronic Hepatitis C
12/2020 - 01/2010
2Portal Hypertension
10/2020 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
10/2020 - 01/2019
2Chronic Hepatitis B
05/2014 - 04/2012
2Hepatitis C
10/2011 - 06/2010
1Fibrosis (Cirrhosis)
12/2020
1Infections
10/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2020
1Disease Progression
10/2020
1Diabetes Mellitus
01/2019

Drug/Important Bio-Agent (IBA)

3Antiviral Agents (Antivirals)IBA
12/2020 - 01/2019
3InterferonsIBA
01/2019 - 01/2010
3Ribavirin (Virazole)FDA LinkGeneric
10/2011 - 01/2010
2entecavirFDA Link
05/2014 - 04/2012
1AlbuminsIBA
10/2020
1Interferon-alpha (Interferon Alfa)IBA
01/2010

Therapy/Procedure

2Liver Transplantation
12/2020 - 10/2020
1Therapeutics
10/2020
1Organ Transplantation
10/2020
1Aftercare (After-Treatment)
01/2019
1Kidney Transplantation
04/2012